Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Celon Pharma SA
8RPCurrent price
5.69 EUR
0 EUR (0.00%)
Last closed
25.55 PLN
Company
www.celonpharma.com
ISIN
PLCLNPH00015
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Frankfurt Exchange
Capitalization
1 392 354 358 PLN
Yield for 12 month
+63.75 %
1Y
3Y
5Y
10Y
15Y
8RP
Celon Pharma S.A., an integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. operates as a subsidiary of Glatton Sp. z o.o. Address: Ogrodowa 2A, Lomianki, Poland, 05-092
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
114.50 PLNP/E ratio
77.42Dividend Yield
0.32 %Current Year
+163 779 633 PLN
Last Year
+161 309 896 PLN
Current Quarter
+53 381 757 PLN
Last Quarter
+34 667 956 PLN
Current Year
+97 210 347 PLN
Last Year
+95 096 277 PLN
Current Quarter
+36 222 126 PLN
Last Quarter
+21 639 826 PLN
Key Figures 8RP
1 year
3 years
5 years
10 years
EBITDA
-13 561 128 PLN
Operating Margin TTM
PE Ratio
77.42
Return On Assets TTM
-4.76 %
PEG Ratio
–
Return On Equity TTM
-9.83 %
Wall Street Target Price
114.50 PLN
Revenue TTM
206 035 123 PLN
Book Value
8.69 PLN
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-3.40 %
Dividend Yield
0.32 %
Gross Profit TTM
143 625 235 PLN
Earnings per share
0.33 PLN
Diluted Eps TTM
0.33 PLN
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-21.99 %
Dividend Analytics 8RP
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
-67.00 %Consecutive Years
–5Y Average Payout Ratio
-17.00 %Dividend History 8RP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
0.080
Ex Dividend Date
27.06.2024
Forward Annual Dividend Yield
0.31 %
Last Split Factor
–
Payout Ratio
17.33 %
Last Split Date
–
Dividend Date
–
Stock Valuation 8RP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
77.42
Forward PE
–
Enterprise Value Revenue
7.28
Price Sales TTM
6.76
Enterprise Value EBITDA
16.21
Price Book MRQ
2.71
Financials 8RP
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 8RP
For 52 weeks
14.49 PLN
32.78 PLN
50 Day MA
26.34 PLN
Shares Short Prior Month
–
200 Day MA
23.02 PLN
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart